| |
| |
|
| Insider
Information: |
Silvernail Lauren P |
| Relationship: |
|
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
207,068 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,945,422 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
207,068 |
|
|
| Total
Value |
$1,945,422 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -60.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ISTA Pharmaceuticals Inc |
ISTA |
CFO & VP Corporate Dev... |
2012-06-06 |
0 |
2005-05-12 |
0 |
Premium* |
|
|
Revance Therapeutics, Inc. |
RVNC |
CFO & CBO |
2018-05-22 |
65,497 |
2014-05-19 |
0 |
Premium* |
|
|
Evolus Inc |
EOLS |
See Remarks |
2022-05-18 |
141,571 |
2018-05-29 |
0 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
|
2024-03-11 |
0 |
2023-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
• – – |
2017-03-16 |
4 |
D |
$19.20 |
$24,366 |
D/D |
(1,269) |
38,359 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-02-02 |
4 |
D |
$6.15 |
$10,344 |
D/D |
(1,682) |
56,438 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, Secretary & EVP Corp Dev. |
• – – |
2015-05-19 |
4 |
D |
$25.94 |
$45,473 |
D/D |
(1,753) |
21,517 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
• – – |
2016-05-19 |
4 |
D |
$17.11 |
$29,994 |
D/D |
(1,753) |
29,942 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
• – – |
2017-05-22 |
4 |
S |
$20.20 |
$36,212 |
D/D |
(1,793) |
36,566 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-08-11 |
4 |
B |
$4.28 |
$10,705 |
D/D |
2,500 |
96,505 |
2.74 |
- |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2019-05-31 |
4 |
S |
$13.53 |
$35,352 |
D/D |
(2,612) |
27,388 |
0 |
- |
|
| EOLS |
Evolus Inc |
See Remarks |
• – – |
2021-01-25 |
4 |
AS |
$7.46 |
$20,135 |
D/D |
(2,699) |
90,689 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO & CBO |
• – – |
2018-05-22 |
4 |
AS |
$30.25 |
$86,924 |
D/D |
(2,874) |
65,497 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
• – – |
2018-03-22 |
4 |
AS |
$30.85 |
$105,839 |
D/D |
(3,431) |
68,371 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
CFO |
• – – |
2005-05-12 |
4 |
B |
$7.51 |
$37,699 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • – |
2023-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
|
– • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2006-02-16 |
4 |
A |
$0.00 |
$6 |
D/D |
5,600 |
12,721 |
|
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
CFO |
• – – |
2006-02-16 |
4 |
A |
$0.00 |
$6 |
D/D |
5,600 |
10,600 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
CFO |
• – – |
2007-02-02 |
4 |
A |
$0.00 |
$7 |
D/D |
7,000 |
17,600 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, Secretary & EVP Corp Dev. |
• – – |
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,290 |
23,270 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
• – – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,125 |
74,090 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
CFO |
• – – |
2009-02-03 |
4 |
A |
$0.00 |
$9 |
D/D |
9,000 |
52,353 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
CFO |
• – – |
2010-02-02 |
4 |
A |
$0.00 |
$9 |
D/D |
9,000 |
60,584 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
• – – |
2016-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
31,695 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
• – – |
2017-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
40,691 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
• – – |
2017-11-07 |
4 |
OE |
$8.70 |
$87,000 |
D/D |
10,000 |
59,006 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
• – – |
2017-11-07 |
4 |
AS |
$26.83 |
$268,267 |
D/D |
(10,000) |
49,006 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
• – – |
2018-03-07 |
4 |
AS |
$31.50 |
$315,000 |
D/D |
(10,000) |
72,954 |
0 |
- |
|
78 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
